Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 15, 2015 - Issue 1
Submit an article Journal homepage
700
Views
18
CrossRef citations to date
0
Altmetric
Drug Profile

Pertuzumab in combination with trastuzumab and docetaxel for HER2-positive metastatic breast cancer

Hidemi KawajiriCorrespondence[email protected]
,
Tsutomu TakashimaDepartment of Surgical Oncology, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan
,
Shinichiro KashiwagiDepartment of Surgical Oncology, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan
,
Satoru NodaDepartment of Surgical Oncology, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan
,
Naoyoshi OnodaDepartment of Surgical Oncology, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan
&
Kosei HirakawaDepartment of Surgical Oncology, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan
Pages 17-26 | Published online: 12 Dec 2014

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Michael Dobosz, Ute Haupt & Werner Scheuer. (2017) Improved decision making for prioritizing tumor targeting antibodies in human xenografts: Utility of fluorescence imaging to verify tumor target expression, antibody binding and optimization of dosage and application schedule. mAbs 9:1, pages 140-153.
Read now

Articles from other publishers (17)

Rui-qi Qiao, Hao-Ran Zhang, Rong-Xing Ma, Rui-feng Li & Yong-cheng Hu. (2022) Prognostic Factors for Bone Survival and Functional Outcomes in Patients With Breast Cancer Spine Metastases. Technology in Cancer Research & Treatment 21, pages 153303382211226.
Crossref
Kevin Dzobo. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology 408 422 .
Miguel Angel Galván Morales, Raúl Barrera Rodríguez, Julio Raúl Santiago Cruz & Luis M. Teran. (2020) Overview of New Treatments with Immunotherapy for Breast Cancer and a Proposal of a Combination Therapy. Molecules 25:23, pages 5686.
Crossref
Koji Takada, Shinichiro Kashiwagi, Wataru Goto, Yuka Asano, Katsuyuki Takahashi, Tsutomu Takashima, Shuhei Tomita, Masahiko Ohsawa, Kosei Hirakawa & Masaichi Ohira. (2018) Use of the tumor-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to combination therapy with pertuzumab, trastuzumab, and docetaxel for advanced HER2-positive breast cancer. Journal of Translational Medicine 16:1.
Crossref
Shinichiro Kashiwagi, Gen Tsujio, Yuka Asano, Wataru Goto, Koji Takada, Katsuyuki Takahashi, Tamami Morisaki, Hisakazu Fujita, Tsutomu Takashima, Shuhei Tomita, Masahiko Ohsawa, Kosei Hirakawa & Masaichi Ohira. (2018) Study on the progression types of cancer in patients with breast cancer undergoing eribulin chemotherapy and tumor microenvironment. Journal of Translational Medicine 16:1.
Crossref
Shingo Maeda, Hirotaka Tomiyasu, Masaya Tsuboi, Akiko Inoue, Genki Ishihara, Takao Uchikai, James K. Chambers, Kazuyuki Uchida, Tomohiro Yonezawa & Naoaki Matsuki. (2018) Comprehensive gene expression analysis of canine invasive urothelial bladder carcinoma by RNA-Seq. BMC Cancer 18:1.
Crossref
Sumayah Al-Mahmood, Justin Sapiezynski, Olga B. Garbuzenko & Tamara Minko. (2018) Metastatic and triple-negative breast cancer: challenges and treatment options. Drug Delivery and Translational Research 8:5, pages 1483-1507.
Crossref
Nicholas Thomford, Dimakatso Senthebane, Arielle Rowe, Daniella Munro, Palesa Seele, Alfred Maroyi & Kevin Dzobo. (2018) Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery. International Journal of Molecular Sciences 19:6, pages 1578.
Crossref
Mariam Abotaleb, Peter Kubatka, Martin Caprnda, Elizabeth Varghese, Barbora Zolakova, Pavol Zubor, Radka Opatrilova, Peter Kruzliak, Patrik Stefanicka & Dietrich Büsselberg. (2018) Chemotherapeutic agents for the treatment of metastatic breast cancer: An update. Biomedicine & Pharmacotherapy 101, pages 458-477.
Crossref
Kimberly-Anne Tan, Jiong Hao Tan, Aye Sandar Zaw, Joel Yong Hao Tan, Hwee Weng Dennis Hey & Naresh Kumar. (2018) Evaluation of Prognostic Factors and Proposed Changes to the Modified Tokuhashi Score in Patients With Spinal Metastases From Breast Cancer. Spine 43:7, pages 512-519.
Crossref
Amber JohnsonYekaterina B. KhotskayaLauren BruscoJia ZengVijaykumar HollaAnn M. BaileyBeate C. LitzenburgerNora S. SánchezMd Abu ShufeanSarina Piha-PaulVivek SubbiahDavid HongMark RoutbortRussell BroaddusKenna R. Mills ShawGordon B. MillsJohn MendelsohnFunda Meric-Bernstam. (2017) Clinical Use of Precision Oncology Decision Support. JCO Precision Oncology:1, pages 1-12.
Crossref
Keith T. Schmidt, Cindy H. Chau, Douglas K. Price & William D. Figg. (2016) Precision Oncology Medicine: The Clinical Relevance of Patient-Specific Biomarkers Used to Optimize Cancer Treatment. The Journal of Clinical Pharmacology 56:12, pages 1484-1499.
Crossref
C. Rory Goodwin, Nancy Abu-Bonsrah, Laurence D. Rhines, Jorrit-Jan Verlaan, Mark H. Bilsky, Ilya Laufer, Stefano Boriani, Daniel M. Sciubba & Chetan Bettegowda. (2016) Molecular Markers and Targeted Therapeutics in Metastatic Tumors of the Spine. Spine 41:20, pages S218-S223.
Crossref
Mei Liu, Zhiyang Li, Jingjing Yang, Yanyun Jiang, Zhongsi Chen, Zeeshan Ali, Nongyue He & Zhifei Wang. (2016) Cell-specific biomarkers and targeted biopharmaceuticals for breast cancer treatment. Cell Proliferation 49:4, pages 409-420.
Crossref
Ozan Yazici. (2016) Targeted therapies in gastric cancer and future perspectives. World Journal of Gastroenterology 22:2, pages 471.
Crossref
Sergej Skvortsov, Christoph R. Arnold, Paul Debbage, Peter Lukas & Ira Skvortsova. (2015) Proteomic approach to understand metastatic spread. PROTEOMICS - Clinical Applications 9:11-12, pages 1069-1077.
Crossref
Wei-Jia Wang, Yuan-Yuan Lei, Jin-Hong Mei & Chun-Liang Wang. (2015) Recent Progress in HER2 Associated Breast Cancer. Asian Pacific Journal of Cancer Prevention 16:7, pages 2591-2600.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.